Neurology -- Correspondence for Goetz et al., 55 (6) 789-794

HOME

HELP

FEEDBACK

SUBSCRIPTIONS

ARCHIVE

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):
Year:		Vol:		Page:

Correspondence: When an article is eligible for submission of Correspondence, a link to the response form is available within the full-text article. You must be a current subscriber who has activated the online portion of your subscription in order to send a Correspondence. Any reader can read published Correspondence.

Correspondence to:

ARTICLES:
C. G. Goetz, L. M. Blasucci, S. Leurgans, and E. J. Pappert
Olanzapine and clozapine: Comparative effects on motor function in hallucinating PD patients
Neurology 2000; 55: 789-794 [Abstract] [Full text] [PDF]

Correspondence:
Submit a response to this article

Correspondence published:

Reply to Dr. Leucht: Christopher Goetz (24 May 2001)

Olanzapine versus clozapine for hallucinating PD patients - a psychiatrist's perspective: Stefan Leucht (16 May 2001)

Olanzapine for psychosis in Parkinson's Disease: Daniel S Sa, Anthony E Lang (13 March 2001)

Reply to Dr. Leucht 24 May 2001

Christopher Goetz
Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL
Send Correspondence to journal:
Re: Reply to Dr. Leucht

cgoetz{at}rush.edu Christopher Goetz

Olanzapine versus clozapine for hallucinating PD patients - a psychiatrist's perspective 16 May 2001

Stefan Leucht,
Medical Doctor
Department of Psychiatry, Technische Universität München, Ismaningerstr. 22, 81675 Munich, Germany
Send Correspondence to journal:
Re: Olanzapine versus clozapine for hallucinating PD patients - a psychiatrist's perspective

Stefan.Leucht{at}Lrz.tu-muenchen.de Stefan Leucht

Olanzapine for psychosis in Parkinson's Disease 13 March 2001

Daniel S Sa
Movement Disorders Clinic, Toronto Western Hospital, University of Toronto,
Anthony E Lang
Send Correspondence to journal:
Re: Olanzapine for psychosis in Parkinson's Disease

danielssa{at}hotmail.com Daniel S Sa, et al.